Shockwave Medical, Inc. (SWAV)
| Market Cap | 12.57B |
| Revenue (ttm) | 787.97M +41.4% |
| Net Income | 163.50M -32.0% |
| EPS | 4.26 -32.7% |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,947,054 |
| Open | 334.85 |
| Previous Close | 334.75 |
| Day's Range | 334.75 - 334.85 |
| 52-Week Range | 157.00 - 334.90 |
| Beta | 0.88 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About SWAV
Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system... [Read more]
Financial Performance
In 2023, ShockWave Medical's revenue was $730.23 million, an increase of 49.11% compared to the previous year's $489.73 million. Earnings were $147.28 million, a decrease of -31.81%.
Financial StatementsNews
Rubicon Point Partners Acquires Shockwave Medical Headquarters Campus in Santa Clara, California
SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Rubicon Point Partners (“RPP”) announces the acquisition of the Shockwave Medical headquarters, a 201,078-square-foot, four-building R&D campus in Santa...
J&J's $13 billion bid for Shockwave turns to Wall Street for funding
Johnson & Johnson JNJ, +0.29% rolled out a four-part bond on Monday to help fund its planned $13 billion acquisition of Shockwave Medical, underscoring how the Federal Reserve's rate hikes haven't dul...
SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Shockwave Medica...
Shockwave Medical Reports First Quarter 2024 Financial Results
SANTA CLARA, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of c...
Johnson & Johnson (JNJ) Shockwave Deal & Earnings Takeaways
CFRA views the newly announced $13.1B Johnson & Johnson (JNJ) shockwave deal as positive. David Toung and Sel Hardy discuss the takeaways from Johnson & Johnson's earnings.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, INRD
NEW YORK , April 9, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches...
Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World' Study
Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory Angina Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc.
NEW YORK, April 5, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Shockwave Medical, Inc. (NASDAQ: SWAV) and its board of directors concerning the propose...
J&J Acquires Shockwave Medical to Boost Its Cardiovascular Treatment Portfolio
Johnson & Johnson (JNJ) announced Friday it was buying Shockwave Medical (SWAV) for $13.1 billion in cash, pushing shares of the maker of cardiovascular catheters to near all-time highs.
Johnson & Johnson to Buy Shockwave Medical in $13.1 Billion Deal
The healthcare giant said the addition of the medical-device maker would expand its MedTech cardiovascular portfolio.
Johnson & Johnson Buys Shockwave For $13.1 Billion In Latest Cardio Deal
Johnson & Johnson will acquire Shockwave Medical in a deal valued at $13.1 billion, according to a joint statement Friday, the latest acquisition by the pharmaceutical firm over the last two years as ...
Johnson & Johnson to buy Shockwave Medical for $12.5 billion
Shockwave Medical Inc (NASDAQ: SWAV) is in the green today after Johnson & Johnson (NYSE: JNJ) said it will buy the medical device maker for $12.5 billion. Shockwave Medical stock priced at a premium ...
Johnson & Johnson to Buy Shockwave Medical. It's a Cardio Health Play.
Johnson & Johnson is buying the medical-devices maker for a total enterprise value of about $13.1 billion.
Johnson & Johnson to acquire Shockwave Medical in $13.1 billion deal
Johnson & Johnson JNJ, -1.14% has agreed to acquire Shockwave Medical Inc. SWAV, -0.23% in an all-cash deal with an enterprise value of about $13 billion, the companies said Friday. J&J will pay $335 ...
Johnson & Johnson to buy Shockwave Medical for $12.5 bln
Johnson & Johnson will buy medical device maker Shockwave Medical for about $12.5 billion, the companies said on Friday, helping the healthcare conglomerate boost its portfolio of medical devices.
Johnson & Johnson to Acquire Shockwave Medical
NEW BRUNSWICK, N.J. & SANTA CLARA, Calif.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) and Shockwave Medical, Inc. (Nasdaq: SWAV) (“Shockwave”) today announced that they have entered into a definit...
Shockwave Medical shares rise on report of acquisition talks with Johnson & Johnson
Shares of medical-device maker Shockwave Medical Inc. rose Tuesday following a report that Johnson & Johnson was in talks to acquire the company.
Johnson & Johnson Considers Deal for Shockwave Medical
The California-based maker of medical devices that treat cardiovascular diseases has a market value of nearly $12 billion.
Johnson & Johnson considers deal to buy Shockwave Medical, WSJ reports
Johnson & Johnson is in talks to buy medical device maker Shockwave Medical , the Wall Street Journal reported on Tuesday.
Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare Conference
SANTA CLARA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of...
Shockwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results
SANTA CLARA, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...
Shockwave Medical Appoints Renee Gaeta as Chief Financial Officer
SANTA CLARA, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...
Shockwave Medical Provides Quarterly Earnings Release Dates for 2024
SANTA CLARA, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- January 8, 2024 – Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for...
Shockwave Medical to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
SANTA CLARA, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment car...
Shockwave Medical to Participate in the Piper Sandler 35th Annual Healthcare Conference
SANTA CLARA, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment car...